Fondaparinux dosage forms and strengths: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Abdurahman Khalil (talk | contribs)
nocaptcha
3,981 edits
No edit summary
Alejandro Lemor (talk | contribs)
nocaptcha, Administrators
7,091 edits
←Redirected page to Fondaparinux#How Supplied
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Fondaparinux#How Supplied]]
{{Fondaparinux}}
{{CMG}}; {{AE}} {{AZ}}


==Dosage Forms And Strengths==
Single-dose, prefilled syringes containing either 2.5 mg, 5 mg, 7.5 mg, or 10 mg of fondaparinux.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ARIXTRA (FONDAPARINUX SODIUM) INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05bb2dd4-5fb5-4ec9-29a8-d200e62d1a8f | publisher =  | date =  | accessdate =  }}</ref>
==References==
{{Reflist}}
{{FDA}}
[[Category: Cardiovascular Drugs]]
[[Category: Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category: Drug]]
[[Category: Anticoagulants]]

Revision as of 16:13, 21 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Fondaparinux_dosage_forms_and_strengths&oldid=996840"